We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Established in 2011, Crowdcube has become the market leader in the equity crowdfunding sector. The company has a 40% share of the UK market with over 620,000 investors registered on the platform that have invested more than £561m in pitches. This has resulted in nearly 800 successful campaigns and Crowdcube's revenue increasing by 33% from H1 2017 to H1 2018. Funds are being raised to scale the business by expanding further in the UK, as well as overseas.
days to go: Expired investment: £7,918,180
CapitalRise is an online property lending platform offering market-leading returns of 7-12% per annum from secured lending to prime real estate. Till date, the company has lent £71.9 million against assets worth over £410 million, repaid £28 million of capital and return to customers, and saw a 354% increase in revenues in 2019. CapitalRise is ranked #1 in both 1-year and 3-year net returns as verified by leading loan analytics firm, Brismo. The company has won awards including, the British Bank Awards 2020 - Best Alternative Finance Provider. It has also received press coverage from publications such as The Times, Forbes and Daily Express. It will use the investment to take advantage of the UK government's Future Fund given the positive feedback from its investors, improve its technology platforms, further its marketing and lending initiatives, and satisfy customer expectations.
days to go: Expired investment: £2,214,280
Nutmeg is on a mission to equalize capital management, which can help people in conquering their life goals. The company is the largest digital wealth manager brand, and it manages over £1.7bn for over 70,000 customers in the UK. It offers three investment styles through a pension account, a general investment account, an ISA and a Lifetime ISA. Furthermore, the company has launched in Taiwan, with B2B and international plans. The company has ambitious growth plans and to emerge as the fastest and trusted growing digital wealth manager in the world.
days to go: Expired investment: £3,783,549
Talon is a cloud-based SaaS platform and an on-demand workforce management software. It is an innovative software for handling freelancers, direct work engagements, and private talent pools. The company offers 3 key benefits: reducing costs, managing risks, and maximising value. Talon has provided solutions to Reed Consultancy and Spend Matters. The company's aim is to be the top enterprise SaaS platform for on-demand workforce management worldwide. With a proven product, revenue-generating customers and established channels to market & live in, it is looking to move quickly and seize opportunities to grow.
days to go: Expired investment: £100,000
Chip is one of the fastest-growing Fintech companies in the UK. Chip has built an app that uses the user's banking app to make personalised decisions about their money. Its user base has doubled since its previous fundraising in 2018. The company has 153,000 accounts, and it has processed more than £130m of savings. ChipX is the company's revolutionary returns platform and it has a waiting list of more than 50,000 people. The company is a winner of the British Bank Award, 2 Crowdcube awards, and 1 World Banking Award. It has welcomed many management executives from Funding Circle, Monzo, and Purple Bricks. Chip is now scaling with market-leading returns on ChipX. It aims to build the biggest savings account in the world. With the proceeds, the company will double its team and expand ChipX in the €10 trillion European savings market.
days to go: Expired investment: £3,768,260
An online marketplace offering people to invest in global properties. Wealth Migrate allows investors to diversify their portfolios through a safe and simple platform that uses SMART Investing technology. Investors from 55 countries have performed over 2100 transactions, with each transaction averaging £29.4k and receiving returns ranging from 7% to 12%. In 2017, over £1.1m of revenue was generated from 846 transactions. Wealth Migrate's main sources of income are derived from equity raising fees, investment management fees and exit fees on the demand side. The company intends to reduce its minimum investment amount to attract more customers to the marketplace.
days to go: Expired investment: £1,980,450
BioSure HIV Self Test allows for private testing in a time and place convenient to the user. The test is discreetly delivered in the post and once everything is finished all the testing equipment can be thrown away in the bag provided with the usual rubbish. 
days to go: Expired investment: £495,459
Please watch the video for more information
days to go: Expired investment: £215,000
YAYZY has created a platform that calculates the carbon footprint of a user using their spending data land helps the user make up for it using carbon offsets and guides the user towards more sustainable choices. The company believes that the shift in the use of money from high carbon to low carbon choices will accelerate the transition to a new era of sustainability and responsibility. YAYZY raised a £120,000 pre-seed amount, experienced a 26% organic week-on-week growth only driven by referrals and is in conversation with three major banks that are interested in using its technology. YAYZY will use the investment to launch its Android app, convert 25% of users to subscriptions, introduce impact investing, and onboard at least two B2B customers.
days to go: Expired investment: £722,793
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph